Related references
Note: Only part of the references are listed.Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4+ FoxP3+ regulatory T cells
Xin Chen et al.
IMMUNOLOGY (2011)
Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells
Xin Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
CD103 is a hallmark of tumor-infiltrating regulatory T cells
David Anz et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Depletion of CD4+CD25+regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model
H. Hong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Tumor-Associated Lymphocytes and Increased FoxP3+ Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer
Jena D. French et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B. Cambien et al.
BRITISH JOURNAL OF CANCER (2009)
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Sebastian Attig et al.
CANCER RESEARCH (2009)
Dynamic Behavior and Function of Foxp3+ Regulatory T Cells in Tumor Bearing Host
F. Xiao-Feng Qin
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
CD4+CD25+CD127low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
Li-Song Shen et al.
CLINICAL IMMUNOLOGY (2009)
Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
CD28 and CTLA-4 coreceptor expression and signal transduction
Christopher E. Rudd et al.
IMMUNOLOGICAL REVIEWS (2009)
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Francois M. Lemoine et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effector/Memory but Not Naive Regulatory T Cells Are Responsible for the Loss of Concomitant Tumor Immunity
Yung-Chang Lin et al.
JOURNAL OF IMMUNOLOGY (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Xuyu Zhou et al.
NATURE IMMUNOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
In vivo-activated CD103(+)CD4(+) regulatory T cells ameliorate ongoing chronic graft-versus-host disease
Dongchang Zhao et al.
BLOOD (2008)
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
Rachael A. Clark et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge:: Broad expression of the FoxP3 locus in epithelial cells:: A caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells
Guo-Yun Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide
K. Giannopoulos et al.
LEUKEMIA (2008)
Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease
Blythe D. Sather et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses
Geoffrey L. Stephens et al.
JOURNAL OF IMMUNOLOGY (2007)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma
Sameer A. Siddiqui et al.
CLINICAL CANCER RESEARCH (2007)
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
Sarah E. Allan et al.
INTERNATIONAL IMMUNOLOGY (2007)
Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β
Suchita Nadkarni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke et al.
PLOS ONE (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
K Khazaie et al.
SEMINARS IN CANCER BIOLOGY (2006)
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
CA Wysocki et al.
BLOOD (2005)
Essential role for CD103 in the T cell-mediated regulation of experimental colitis
O Annacker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
JN Stoop et al.
HEPATOLOGY (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
M Kleinewietfeld et al.
BLOOD (2005)
Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
JD Fontenot et al.
IMMUNITY (2005)
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells
J Huehn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Expression of the integrin αEβ7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells
J Lehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
